Found 0 matching trials
BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations PHASE1 This is an open-label, non-randomized, multi-cohort, multi-center Phase Ia/...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy N/A This is study to investigate the plasma free amino acids profile in patient...
Show More Location
Multiple Locations
Learn More & Join Trial
RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma PHASE1 This phase I/Ib trial tests the side effects, best dose, tolerability, and ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations PHASE2 Patients with metastatic or unresectable locally advanced malignancies harb...
Show More Status
Active Not Recruiting
Learn More & Join Trial
WOOP VA: Promoting Weight Management in Primary Care NA Approximately 40% of Veterans have obesity and are at increased risk for ca...
Show More Location
VA NY Harbor Healthcare System, New York, NY
Learn More & Join Trial
A Study of LY2228820 in Participants With Advanced Cancer PHASE1 The objective of this study is to determine a safe dose of LY2228820 that m...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer PHASE2 This Phase 2 Open-label Study examines the efficacy, safety, tolerability, ...
Show More Location
Yale Cancer Center
Learn More & Join Trial
Perceptions of and Reactions to Ultra-Processed Menu Label Designs NA The primary objective of this study is to explore perceptions and understan...
Show More Location
Johns Hopkins Bloomberg School of Public Health
Treatments Being Tested
Ultra-Processed, Red, Icon-plus-text Labels Contains Food Additives, Red, Icon-plus-text Labels Warning Ultra-Processed, Red, Icon-plus-text Labels Warning UPF, Red, Icon-plus-text Labels Ultra-Processed, Yellow, Icon-plus-text Labels Contains Food Additives, Yellow, Icon-plus-text Labels Warning Ultra-Processed, Yellow, Icon-plus-text Labels Warning UPF, Yellow, Icon-plus-text Labels Ultra-Processed, Red, Text-only Labels Contains Food Additives, Red, Text-only Labels Warning Ultra-Processed, Red, Text-only Labels Warning UPF, Red, Text-only Labels Ultra-Processed, Yellow, Text-only Labels Contains Food Additives, Yellow, Text-only Labels Warning Ultra-Processed, Yellow, Text-only Labels Warning UPF, Yellow, Text-only Labels Learn More & Join Trial
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers PHASE1 The study consists of two parts: Drug Interaction (Pharmacokinetic) Phase a...
Show More Location
Huntsman Cancer Institute
Learn More & Join Trial
Prandial Metabolic Phenotype in Adults NA Previous studies suggest that changes in metabolism due to the effects of a...
Show More Location
Human Clinical Research Facility
Learn More & Join Trial